What We're Reading: Page 375
Industry reads hand-picked by our editors
Apr 02, 2015
-
Reuters
India to reportedly add TB, AIDS drugs to price cap list
-
Reuters
Merck, NewLink Ebola vaccines appear safe and effective
-
In-Pharmatechnologist
Peer review journal cheating scandal rages on
-
FierceBiotech
Sanofi strikes $120M drug design deal with Schrödinger
Apr 01, 2015
-
Wall Street Journal
US pharmacists' group urges members not to participate in executions
-
Bloomberg
Former Allergan CEO Pyott making off with $534M cash after stock sale
-
Statesman Journal
Oregon 'Right to Try' bill passes House committee
-
FiercePharma
Gilead chief Martin gets a 23% pay hike
-
Pharma Times
GW Pharma tests marijuana med in phase III epilepsy trial
Mar 31, 2015
-
Reuters
BioCryst wins US contract to continue Ebola drug development
-
Bloomberg
Quintiles and Quest join forces to form clinical trials mega-venture
-
StreetInsider
Merck, Syndax Pharma to collaborate on cancer trial using Keytruda
-
FierceBiotech
Fujifilm acquires pioneering stem cell firm Cellular Dynamics for $307M
Mar 30, 2015
-
Reuters
Sanofi may not be on pharma's M&A bandwagon
-
Bloomberg
Horizon strikes $1.1 billion deal for Hyperion and its orphan drugs
-
ProPublica
Medicare spent 15 times as much on hep C drugs last year
-
Bloomberg
Bucking DTC trend, Pfizer spent $1.4 billion on ads in 2014
-
FiercePharma
Baxter execs nab big bucks in midst of Baxalta spinoff
Mar 27, 2015
-
Wall Street Journal
WHO suggest EU cooperation to lower Rx prices
-
Yahoo News
EU approves Orexigen obesity treatment
-
Bloomberg
J&J, Google to team up on robotic surgeries
-
HHS
HHS' plan to fight opioid drug overdoses
Mar 26, 2015
-
Reuters
British prime minister apologizes for infected blood during 70s and 80s for hemophiliacs
-
Bloomberg
Novartis CEO says that it's ok (and right) to drop investigational products that aren't working
-
The Street
Celladon heart failure study looms large
-
Yahoo Finance
Regulus nabs orphan designation from EU for RG-102 for Alport Syndrome
-
Sun Pharma: After Ranbaxy buyout, we'll work hard to regain regulators' trust
Mar 25, 2015
-
In-Pharmatechnologist
The FDA's new plans for inspections in India
-
Wall Street Journal
Compounding pharmacist trade group discourages supplying lethal injection meds
-
Irish Times
Pharmacyclics execs to rake in $4 billion after AbbVie sale
-
Bloomberg
Vertex cystic fibrosis drug disappoints in trial
-
FiercePharma
The surprising disease that's spiking Rx spending
Previous
